Since both Trx1 and DJ-1 target the tumour suppressor activity of PTEN, co-inhibition of both of these antioxidant molecules may prove an effective approach for the therapeutic intervention of chemotherapy-resistant forms of cancer. Here, TXN is linked to cancer.